| Dr Aaron Leroy Craig, DO | |
|
600 Caisson Hill Rd, Fort Riley, KS 66442-7037 | |
| (785) 239-7377 | |
| (785) 239-7249 |
| Full Name | Dr Aaron Leroy Craig |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 600 Caisson Hill Rd, Fort Riley, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871856724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 05-39192 (Kansas) | Primary |
| 207R00000X | Internal Medicine | 05-39192 (Kansas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera Mckennan Hospital & University Health Center | Sioux falls, SD | Hospital |
| Avera Heart Hospital Of South Dakota | Sioux falls, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
News Archive
Latest figures for MRSA show there was a 6.4% fall in the number of cases of blood stream infection reported to the Health Protection Agency from January - March 2007.
Viruses are true experts at importing genetic material into the cells of an infected organism. This trait is now being exploited for gene therapy, in which genes are brought into the cells of a patient to treat genetic diseases or genetic defects. Korean researchers have now made an artificial virus. As described in the journal Angewandte Chemie, they have been able to use it to transport both genes and drugs into the interior of cancer cells.
Mary Agnes Carey, associate editor of CQ HealthBeat, discusses testimony by Government Accountability Office officials about SCHIP expansion guidelines, compromise on a Senate health information technology bill and a request for increased funding from FDA's top official in this week's "Health on the Hill from kaisernetwork.org and CQ."
Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, has announced new data affirming the effectiveness of multi-gene panel testing (MGPT) in identifying TP53 gene mutations in people who might otherwise not have been tested. The findings, presented as a poster at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore, includes data collected from more than 25,000 individuals having TP53 testing, of which 187 were positive. The tested cohort is the largest to date from a single testing laboratory.
RaQualia Pharma Inc. today announced the signing of a license agreement with CJ CheilJedang Co. (CJ), granting CJ exclusive rights to develop, manufacture and commercialize RaQualia's 5-HT4 Partial Agonist in Korea, China, Taiwan, India and Southeast Asia.
› Verified 3 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
Latest figures for MRSA show there was a 6.4% fall in the number of cases of blood stream infection reported to the Health Protection Agency from January - March 2007.
Viruses are true experts at importing genetic material into the cells of an infected organism. This trait is now being exploited for gene therapy, in which genes are brought into the cells of a patient to treat genetic diseases or genetic defects. Korean researchers have now made an artificial virus. As described in the journal Angewandte Chemie, they have been able to use it to transport both genes and drugs into the interior of cancer cells.
Mary Agnes Carey, associate editor of CQ HealthBeat, discusses testimony by Government Accountability Office officials about SCHIP expansion guidelines, compromise on a Senate health information technology bill and a request for increased funding from FDA's top official in this week's "Health on the Hill from kaisernetwork.org and CQ."
Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, has announced new data affirming the effectiveness of multi-gene panel testing (MGPT) in identifying TP53 gene mutations in people who might otherwise not have been tested. The findings, presented as a poster at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore, includes data collected from more than 25,000 individuals having TP53 testing, of which 187 were positive. The tested cohort is the largest to date from a single testing laboratory.
RaQualia Pharma Inc. today announced the signing of a license agreement with CJ CheilJedang Co. (CJ), granting CJ exclusive rights to develop, manufacture and commercialize RaQualia's 5-HT4 Partial Agonist in Korea, China, Taiwan, India and Southeast Asia.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Leroy Craig, DO 600 Caisson Hill Rd, Fort Riley, KS 66442-7037 Ph: (785) 239-7377 | Dr Aaron Leroy Craig, DO 600 Caisson Hill Rd, Fort Riley, KS 66442-7037 Ph: (785) 239-7377 |
News Archive
Latest figures for MRSA show there was a 6.4% fall in the number of cases of blood stream infection reported to the Health Protection Agency from January - March 2007.
Viruses are true experts at importing genetic material into the cells of an infected organism. This trait is now being exploited for gene therapy, in which genes are brought into the cells of a patient to treat genetic diseases or genetic defects. Korean researchers have now made an artificial virus. As described in the journal Angewandte Chemie, they have been able to use it to transport both genes and drugs into the interior of cancer cells.
Mary Agnes Carey, associate editor of CQ HealthBeat, discusses testimony by Government Accountability Office officials about SCHIP expansion guidelines, compromise on a Senate health information technology bill and a request for increased funding from FDA's top official in this week's "Health on the Hill from kaisernetwork.org and CQ."
Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, has announced new data affirming the effectiveness of multi-gene panel testing (MGPT) in identifying TP53 gene mutations in people who might otherwise not have been tested. The findings, presented as a poster at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore, includes data collected from more than 25,000 individuals having TP53 testing, of which 187 were positive. The tested cohort is the largest to date from a single testing laboratory.
RaQualia Pharma Inc. today announced the signing of a license agreement with CJ CheilJedang Co. (CJ), granting CJ exclusive rights to develop, manufacture and commercialize RaQualia's 5-HT4 Partial Agonist in Korea, China, Taiwan, India and Southeast Asia.
› Verified 3 days ago
Elliot L. Bass, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-7179 |